BWAY faces its Q2 earnings release tomorrow with a lending market that has quietly tightened this week and a consistent pattern of insider selling running through the spring.
The most notable shift in positioning has been in borrow availability. After spending most of July at comfortable levels — availability above 150% as recently as early August — the ratio has dropped sharply to 111.7% now, down roughly 27% on the week. That remains within the "tight" range rather than extreme, but the direction of travel is clear: more shares are being borrowed relative to supply, and the move has come in the days immediately ahead of tomorrow's earnings print. Cost to borrow reinforces the picture, holding near 13.9% — a level that has been broadly sticky for months, and which classifies as expensive by any standard measure. Shares available to lend have fallen to around 137,000, the lowest reading in the 30-day window captured here.
Short interest itself is a secondary story. The short score has edged up to 49.4 this week from around 47.5 a week ago — a modest but consistent grind higher. The DTC rank of 73 signals it would take meaningful time to cover outstanding positions, which adds some structural friction to any squeeze dynamic. Still, availability has not collapsed to the extreme lows that would suggest an imminent borrow crisis. The setup looks cautious rather than crowded: shorts are building incrementally, not rushing.
Insider activity adds a layer of context worth flagging. Every disclosed transaction in the recent window has been a sale. The Founder and Chief Scientific Officer, Yiftach Roth, sold shares across multiple sessions in late May and early June. The CTO and two separate directors also sold during the same period. The net 90-day insider position works out to net selling of around 41,000 shares, worth roughly $636,000. None of these transactions were large in absolute terms — individually they carry low significance scores — but the unanimity of direction is notable ahead of a result. There were no offsetting purchases from any insider in the reported window.
On the ownership side, Valor Management holds 13.3% of shares — the dominant institutional position. Masters Capital trimmed by 350,000 shares in Q1, while Meitav Investment House added 216,000 in a more recent filing. Harel Mutual Funds made the largest proportional addition, nearly doubling its position to just over one million shares. The holder base is relatively concentrated at 74 total institutions, which means any shift in conviction from the top few holders carries outsized weight for a stock trading at ILS 45.30 — down 5.4% on the week.
The stock's recent note history suggests it has been a strong performer year-to-date, up around 63% at its recent peak, with growth metrics underpinned by 29% year-on-year revenue expansion. The valuation, however, has never been cheap — a P/E above 66 and deeply negative free cash flow leave little margin for a disappointing print. Among correlated peers, DCTH surged 31% on the week and NVCR added 8.5%, while FEMY fell 23% and NRXS dropped 9.4% — the peer basket is moving in opposite directions, offering no clear sector tailwind or headwind to anchor expectations.
Tomorrow's report is the first real test of whether the year-to-date momentum has fundamental legs — the borrow market tightening, the insider selling, and the elevated cost to hold a short position will all resolve quickly once the numbers are out.
See the live data behind this article on ORTEX.
Open BWAY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
